Introduction

Hypertension is a major independent and preventable risk factor of cardiovascular disease (CVD) [1] and physical inactivity contributes to hypertension [2, 3]. Engaging in regular exercise is known to reduce blood pressure (BP) [4, 5] and stimulates physiological adaptations for general health improvements [6]. However, the reduction in BP following exercise training is regulated by multifaceted mechanisms which remain elusive [5, 7]. The renin–angiotensin–aldosterone system (RAAS) is an important regulator of BP [8]. Renin is secreted by the kidney in response to low arterial pressure, sympathetic activation, sodium deficiency or dehydration. Renin converts angiotensinogen to angiotensin-I which is then converted to angiotensin-II by angiotensin-converting enzyme (ACE) [9, 10]. Angiotensin-II is the major mediator of RAAS causing aldosterone release, vasoconstriction and fluid and electrolyte retention to increase blood volume and BP [11,12,13]. Increased RAAS activation may lead to the development of hypertension due to several environmental and physiological factors (e.g. vasoconstriction, fluid and electrolyte imbalances) [14,15,16,17]. Exercise training may exert a counter regulatory effect on the RAAS that initiates vasodilation and cardio-protection, by suppressing angiotensin-II release. A previous meta-analysis has shown that chronic endurance training reduced BP which the authors attributed to reductions in systemic vascular resistance via RAAS and sympathetic nervous system (SNS) mediation [5]. Goessler et al. [18] in a meta-analysis of 11 randomised controlled trials (RCTs) of healthy individuals showed a reduction in plasma renin activity but unchanged angiotensin-II and aldosterone levels. Since the systematic review by Goessler et al., there have been 9 new trials conducted in different clinical populations that now warrant further analysis of the effects of exercise training on the RAAS. The aim of this meta-analysis was to investigate the effect of exercise training on plasma renin activity, angiotensin-II, aldosterone, epinephrine, norepinephrine, urinary sodium, potassium, BP and heart rate (HR). We hypothesised that exercise training would reduce RAAS parameters and SNS activity, and ultimately reduce BP and resting HR. In addition, sub-analyses aimed to explore the effects of health status, medication use, and exercise modality.

Materials and methods

This meta-analysis was registered with the International Prospective Register of Systematic Reviews (PROSPERO) [CRD42021255225] [19]. The review protocol can be accessed at PROSPERO website.

Search strategy

We conducted a systematic literature search in PubMed, Web of Science and the Cochrane Library of Controlled Trials up until 30 November 2022. The search strategy included RAAS key words and in combination with exercise training and MeSH terms. This was supplemented by manually searching reference lists from systematic reviews and eligible studies for additional studies. The strategy for the database searches is documented in the online resources (Supplementary Table S1).

Inclusion and exclusion criteria

We included RCTs in adults (over 18 years) that assessed RAAS parameters after exposing participants to different types of exercise training (e.g. aerobic, resistance or combined) as the main intervention for a minimum of 4 weeks duration. Crossover studies were excluded if the washout period was less than two weeks. Identified studies that did not report any of the required outcomes were excluded.

Two authors (BB, MM) assessed all identified articles independently for eligibility, and consulted two reviewers (MJP, GD) for any disagreement to be resolved.

Comparisons

Included studies compared exercise training intervention group(s) to a non-exposed control (usual care) group or a sham intervention (supervised stretching/callisthenics) group.

Outcome measures

The primary outcome measures were changes in plasma renin activity, angiotensin-II and aldosterone. The secondary outcome measures were change in epinephrine, norepinephrine, urinary sodium and potassium excretion, BP and HR.

Please note that some of the outcome measures mentioned in the initial protocol might not be feasible if the reporting of these is limited and insufficient for meta-analysis. In addition to the protocol, we did include BP and HR measurements as additional outcome measures as these are relevant for a RAAS study.

Data extraction

From each included study we extracted the first author’s name, year of publication, country, study design, type of study population, participants’ baseline characteristics (including age, gender, number of participants, and resting BP). In addition, the characteristics of training interventions (i.e. exercise programs, intensity, duration and frequency of the protocol) and the changes in the desired outcome variables were obtained. Data extraction was conducted independently by two authors (BB, MM) using a predesigned data extraction sheet. Reviewers (GD, MJP, NAS) were consulted for resolution of any disagreements. For outcome data reported in figures only, the WebPlotDigitizer (version 4.5) [20] computer software was used to extract the relevant dataset.

Statistical analyses

Data sets were organised and descriptive analyses performed using Excel 2016 for all included studies. Meta-analyses were completed in Comprehensive Meta-Analysis (CMA) V4 (Biostat Inc, NJ, USA). Where outcome variables were assessed by different methods and reported in different units of measure, the standardised mean difference (SMD) for the outcome measures studied were pooled using a random effects model (DerSimonian-Laird). For two included studies with multiple exercise intervention groups [21, 22], data was combined for the effect size for the parameter measured using ReviewManager 5.4 software (The Nordic Cochrane Centre, Copenhagen, Denmark). Forest plots were generated using CMA to provide visual representation of the effect sizes. Sensitivity analyses were conducted using ‘one study removed’ statistics in CMA for overall assessment of the intervention effect. Sub-analyses were performed on RAAS outcome parameters that were statistically significant and systolic/diastolic BP by health status, medication use, exercise modality and control activity. The level of statistical significance was set at p < 0.05.

Heterogeneity and publication bias

Statistical heterogeneity (I2) was assessed for inconsistency among studies with the values of 25%, 50%, and 75% representing low, moderate, and high degrees of heterogeneity [23]. Publication bias was evaluated by visual inspection of the funnel plot for all outcomes with Egger’s regression test [24].

Quality of study assessment

The validated Tool for the assEssment of Study qualiTy and reporting in EXercise (TESTEX) [25] was used to assess the methodological quality of the included studies. This is a 15-point assessment criteria (5 points for study quality and 10 points for reporting) designed specifically for use in exercise training studies.

Results

The initial searches identified a total of 1708 records plus an additional 5 records through manual searching, 783 duplicate records were removed leaving 930 records for screening. A total of 861 records were excluded after screening titles and abstracts. The remaining 69 full-text articles were assessed for eligibility. A further 51 studies were excluded with reasons provided in the PRISMA flow diagram (Fig. 1). Eighteen studies were included in the quality synthesis and meta-analysis.

Fig. 1
figure 1

PRISMA flow diagram of included studies.

Study characteristics

Of the 18 RCTs [21, 22, 26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41] included in this review, most of the studies [21, 22, 26, 29,30,31, 39] were conducted in the USA (7 studies), Japan had 4 studies [33, 34, 36, 37], Brazil had three studies [32, 38, 40], with one study each in China [41], Italy [35], Poland [28] and Turkey [27]; studies were published between 1987 and 2022. The studies included a total of 803 randomised participants (exercise and control group, n = 458 and 349, respectively). Most studies included both male and female participants except for three trials which included only male [28] or female [27, 39] participants. The median age was 56.7 (range: 47–70.4) years. This review included trials in healthy adults [21, 26, 31, 39], participants with hypertension [22, 32,33,34, 36,37,38, 40, 41] and pre-hypertension [27], as well as patients with heart failure [29, 30, 35], and coronary artery disease [28]. At baseline, the average resting systolic BP was 140.2 mmHg (range 112–162.2 mmHg) and diastolic BP was 84.6 mmHg (range 65–102 mmHg). In 9 trials, participants taking medications either continued their medication [22, 28,29,30, 32, 35, 40] or discontinued [36,37,38] it before the start of the intervention. The duration of the trial interventions varied from 4 to 37 weeks and the frequency ranged from 3 to 7 training sessions per week. The type of exercise adopted by trials included isolated aerobic training in 12 trials [22, 27,28,29,30, 33,34,35,36,37,38,39], resistance training in two trial [26, 40] and two trials employed a combination of aerobic and resistance training [21, 31]. In two trials, participants performed water-based calisthenics and walking [32], and tai chi [41]. The majority of the trials used ‘no exercise’ as a control intervention except in 3 trials where supervised stretching [22, 26] and isometric callisthenics (posture and breathing techniques) [38] were performed to control for placebo effect. The characteristics for included studies are detailed in Table 1.

Table 1 Characteristics of included randomised controlled trials.

Effect of exercise training on the renin–angiotensin–aldosterone system

Nine out of 18 included trials measured angiotensin-II plasma concentration. Exercise training decreased angiotensin-II concentration with SMD −0.71 (95% CI −1.24 to −0.19, p = 0.008; I2 = 79.4%, p < 0.001). Likewise, for the 8 trials measuring aldosterone concentration, pooled analysis showed a reduced SMD −0.37 (95% CI −0.65 to −0.09, p = 0.009; I2 = 28.9%, p = 0.197). However, plasma renin activity (measured in 7 trials) remained unchanged with SMD −0.16 (95% CI −0.73 to 0.41, p = 0.585; I2 = 82.1%, p < 0.001). The results of the training effect on RAAS parameters are displayed in Fig. 2.

Fig. 2: Standardised change in means of RAAS parameters.
figure 2

Forest plots showing the effects of exercise training on angiotensin-II [pg/mL] (A), aldosterone [pg/mL] (B) and plasma renin activity [ng/mL/h] (C) compared with control. A p-value < 0.05 represents a significant pooled standardised difference in means of overall effect. Horizontal lines across each present 95% CI for each study. The diamond represents the 95% CI for pooled estimates of effect of standardised mean difference.

Effect of exercise training on sympathetic nervous system activity and electrolytes

Sympathetic nervous system activity was assessed by plasma norepinephrine and epinephrine levels (Fig. 3). In 8 trials, exercise training reduced norepinephrine with SMD −0.82 (95% CI −1.18 to −0.46, p < 0.001; I2 = 56.8%, p = 0.023). Five trials reported exercise training effect on epinephrine, but there was no change; SMD −0.26 (95% CI −1.39 to 0.860, p = 0.646; I2 = 92.6%, p < 0.001).

Fig. 3: Standardised change in means of sympathetic nervous system activity.
figure 3

Forest plots showing the effects of exercise training on norepinephrine [pg/mL] (A) and epinephrine [pg/mL] (B) compared with control. A p-value < 0.05 represents a significant pooled standardised difference in means of overall effect. Horizontal lines across each present 95% CI for each study. The diamond represents the 95% CI for pooled estimates of effect of standardised mean difference.

The electrolytes assessed included the 24-h urinary sodium and potassium excretion, the recommended gold standard method of measuring an individual’s associations between sodium, potassium and BP [42]. There was no change in sodium excretion (4 trials); SMD 0.13 (95% CI −0.27 to 0.54, p = 0.521; I2 = 0%, p = 0.943) and potassium excretion (3 trials); SMD −0.10 (95% CI −0.66 to 0.46, p = 0.725; I2 = 26.9%, p = 0.255) (Fig. 4).

Fig. 4: Standardised change in means of electrolytes.
figure 4

Forest plots showing the effects of exercise training on 24-h sodium [mmol/d] (A) and potassium [mmol/d] (B) excretion compared with control. A p-value < 0.05 represents a significant pooled standardised difference in means of overall effect. Horizontal lines across each present 95% CI for each study. The diamond represents the 95% CI for pooled estimates of effect of standardised mean difference.

Effect of exercise training on resting blood pressure and heart rate

Overall, exercise training had a significant effect on resting BP but not HR. Systolic BP reduced by a mean difference (MD) −6.2 mmHg (95% CI −9.9 to −2.6, p = 0.001; I2 = 85.4, p < 0.001) and diastolic BP by MD −4.5 mmHg (95% CI −6.9 to −2.1, p < 0.001; I2 = 92.5, p < 0.001) but resting HR MD −3.0 bpm (95% CI −6.0 to 0.4, p = 0.053; I2 = 91.3, p < 0.001) was unchanged (see Supplementary Fig. S1). For studies that reported on blood pressure measures alongside markers of RAAS, the decrease in SBP and DBP was significant for all parameters with the exception of aldosterone and epinephrine. Table 2 summarises the results of exercise training effect on resting BP for all the included studies and for studies reporting on BP alongside each of the outcome parameters (see Supplementary Figs. S2 and S3).

Table 2 Mean net changes in resting blood pressure for studies reporting BP alongside RAAS parameters.

Sensitivity analyses and sub-analyses

‘One study removed’ sensitivity analysis for RAAS parameters, systolic and diastolic BP and heart rate did not indicate that any study overly impacted results (Supplementary Fig. S4). Sub-analyses for the RAAS outcome measures angiotensin-II, aldosterone, norepinephrine and also systolic and diastolic BP when analysed by health status showed reductions in unhealthy participants. This was particularly pronounced in participants with hypertension and those taking medications. Sub-analyses of exercise interventions also showed that aerobic exercise training was more effective in reducing the RAAS outcomes, SBP and DBP than other forms of training (Supplementary Tables S3S7 and Figs. S5S9).

Heterogeneity and publication bias

Statistical heterogeneity across most outcomes was moderate to high. Funnel plots were produced for all parameters (Supplementary Fig. S10). When assessed using Egger’s regression test, visual inspection of the funnel plots showed little evidence of publication bias.

Study quality

Study quality was assessed using the TESTEX scale. Of a maximum 15-point scale the median score was 9 (range 8–12) with higher scores indicating better quality (Supplementary Table S2).

Discussion

The main findings of this meta-analysis demonstrated that angiotensin-II and aldosterone were reduced with exercise training; however, plasma renin activity was unchanged. Plasma norepinephrine decreased but epinephrine was unchanged. There was no change in both 24-h urinary sodium and potassium excretion following exercise training. Collectively, the 14 studies that reported both BP and RAAS markers showed a reduction in overall systolic and diastolic BP, but not HR, after exercise training.

Effect of exercise training on the renin–angiotensin–aldosterone system

In the present study, our pooled data analyses showed exercise training reduced plasma angiotensin-II and aldosterone. This contrasts with the findings reported in the previous meta-analysis [18], and may be due to Goessler et al. including only healthy populations, as angiotensin-II and aldosterone are likely to be elevated in people with heart failure and to a lesser extent in people with hypertension (these populations were subjects of our sub-analyses). The previous study [18] could also be underpowered considering the number of included studies (n = 3 each) for both analyses of angiotensin-II and aldosterone. In contrast, our meta-analysis depicted unchanged plasma renin activity with exercise training while the previous study found reductions. It could be argued that possible renin-independent mechanisms are involved in angiotensin-II formation, with suggested mechanisms such as prorenin activating the prorenin receptor to generate angiotensin-II independent of renin activation [43] and tissue-derived renin to generate angiotensin-II in the circulation [44, 45]. Arnold et al. [46] tested this hypothesis administering the angiotensin-II type 1 (AT1) receptor blocker losartan (50 mg) to older adults with autonomic failure hypertension. Unexpectedly, these authors found increased circulating angiotensin-II levels in people with hypertension and autonomic failure compared with matched healthy controls despite low plasma renin activity; they suggested the formation of additional angiotensin-II was independent of plasma renin activity. In addition, plasma renin activity which is actually a measure of the rate of generation of angiotensin-II in circulation, is usually also affected by environmental factors including lifestyle behaviours [47,48,49,50]. Our pooled data analysis showed no overall change in plasma renin activity, although, some individual studies have reported a reduction in plasma renin activity [22, 32, 51, 52], while others reported no change after exercise training [15, 28, 34,35,36,37, 53]. It is of note that the exercise-related reductions in BP have not been fully elucidated as a combination of different mechanisms are involved which differ in individuals/populations as well as the different exercise training protocols [12, 54, 55]. For example, long-term exercise training induces possible changes in vascular responsiveness as the role of endothelium-driven factors is thought to play important roles in the local regulation of vascular resistance [55]. Nitric oxide, a potent vasodilator, increased [32, 56] and endothelium-1, a potent vasoconstrictor, reduced [32, 57, 58] following exercise training. Additionally, it could be suggested that the timing of data collection in exercise studies, especially in individuals with high BP, may influence change in some cardiovascular variables such as BP and plasma renin activity. It is important to show BP and hormonal changes may be unrelated to humoral factors and plasma volume changes [15]. In patients with essential hypertension, Zhang et al. [59] found decreased BP, plasma renin activity and aldosterone after 1–4 weeks of low-to-moderate-intensity training, which remained stable from 4–10 weeks. These authors reported variations in depressor response in responders versus non-responders to exercise training, as determined by baseline mean BP and humoral factors, but also the involvement of genetics, in their multivariate analysis of the prognostic determinants of the depressor response to exercise therapy.

More importantly, the sub-analyses for angiotensin-II and aldosterone revealed exercise training produced reductions which seemed more effective in participants with hypertension than their healthy counterparts, of which aerobic exercise training was the most effective compared to the other modes of exercise training. Likewise, the sub-analyses of systolic and diastolic BP showed similar exercise training effects. Moreover, there were reductions in systolic and diastolic BP in studies also reporting individual plasma renin activity, and angiotensin-II, but not in studies measuring aldosterone. The non-significant net change in BP for studies also reporting aldosterone may be because 5 [31,32,33, 37, 38] out of the 8 studies included in the aldosterone meta-analysis did not report a reduction in aldosterone.

Effect of exercise training on sympathetic nervous system activity and electrolytes

Assessing the effect of exercise training on SNS activity, our meta-analyses showed a reduction in norepinephrine but not epinephrine. The non-significant reduction in epinephrine may be due to insufficient statistical power due to the small number of studies that assessed epinephrine (5 studies, n = 136 exercise and 93 control group). Regardless of the latter, it could be speculated that improved baroreflex control may have occurred, which would lead to a reduction in sympathetic activity following exercise training [60]. Regular aerobic exercise also enhances endothelial function with ageing in men by reducing oxidative stress and preserving NO bioavailability [61]. Muscle sympathetic nerve activity is favourably altered in people with impaired metaboreflex, mostly resulting from long-term interventions (>16 weeks) including aerobic exercise of moderate to high intensity, performed in isolation or within multimodal training [62].

The reduction in norepinephrine level could be explained by the positive modulation of the autonomic balance by the exercise training effect [35, 63]. Moreover, in humans the plasma epinephrine response to exercise is small compared with that of norepinephrine [64]. Levels of plasma epinephrine increase only when exercise training results in hypoglycaemia at very high intensities [64, 65]. At that point, significant post-training effects may be observed. As such, almost all of the exercise programs adopted in the included studies were of low-to-moderate/vigorous relative intensities (that is, <85% HRmax) which were unlikely to effect a large change in epinephrine levels. Regardless, both relative (subjective measure of exercise intensity specific to an individual’s level of fitness which is based on maximum exercise capacity) and absolute (objective measure) exercise intensity plays a major role in determining the SNS response to exercise training. Thus, the variations in terms of exercise intensity in measuring and comparing activity patterns as well as tracking them over time can introduce some elements of confusion and inconsistency [66]. Assessing the effect of exercise intensity was beyond the scope of this study. Despite the detection of a highly significant reduction in norepinephrine concentration, our meta-analysis of included studies showed no change in resting HR. It could be speculated that either the relative intensity or the duration of the exercise protocols adopted by the majority of the included studies were insufficient to elicit a decreased HR. Considering almost all the participants were >50 years old, exercise training-induced adaptations are potentially affected by aging due to structural and functional changes including a reduction in neuroendocrine function resulting in a decreased responsiveness to homoeostasis disruption [67]. Thus, the aging cardiovascular system may be protected by the benefits of chronic exercise-induced adaptation. A longer training duration (that is from 30 weeks or more) would probably be necessary for older individuals to show a reduction in resting HR [68, 69]. Individual studies [22, 35] with longer training durations (>30 weeks) showed decreases in norepinephrine and a reduction in HR. In hypertensive participants, Hagberg et al. [22] showed reductions in resting HR (8 beats/min; p < 0.01) and norepinephrine (57 pg/mL; p < 0.05) following 9 months of training. Likewise, in chronic heart failure patients, Passino et al. [35] showed reductions in resting HR (from 6 beats/min; p = 0.002) and norepinephrine (from 160 ng/L; p < 0.001) after 9 months of training. Contrary to 10 weeks of training in young healthy adults (mean age 28 years), Greiwe et al. [64] found increases in both epinephrine and norepinephrine at increased exercise intensities with no change in HR comparing before and after training.

The two main electrolytes assessed in the present study were urinary sodium and potassium excretion. The analyses of both 24-h urinary sodium and potassium excretion in exercise vs control groups was unchanged. The reason for this cannot be explained even though our meta-analysis demonstrated a reduction in aldosterone, although there was decreased statistical power due to low number of studies included (that is, for sodium and potassium excretion: 4 and 3 studies, respectively) in the analyses. However, the slight increase in sodium excretion versus the reduction in potassium excretion might suggest improved sodium/potassium exchange following the cumulative effects of chronic exercise training which may have lowered aldosterone level. Aldosterone plays a major role in the regulation sodium reabsorption and potassium secretion [70,71,72]. During prolonged exercise, the body loses water and electrolytes as sweat. Sweating is influenced by several factors that increase in proportion to the rate of workload (including intensity, volume, duration per session or type of exercise) and the environmental temperature, humidity [73, 74] and there is individual variability [75]. Studies have shown that intracellular and plasma (or serum) sodium are higher in hypertensives than their normotensives counterparts [76,77,78,79,80]. The electrolyte responses to exercise training in hypertensives and normotensives may be different due to genetic abnormalities in body fluid and electrolyte homoeostasis [37, 81].

Limitations

This study had limitations including the small sample sizes in the included studies for some measurements which may have been underpowered. In addition, we could not establish a relationship between exercise-induced changes in BP and changes in outcome measures of interest. We acknowledge that only included studies that measured markers of RAAS as well as BP and HR were included in the review, indicating that the impact of exercise training on systemic hemodynamics is likely not reflected by this study. This analysis was also limited by the varied health and medication status of participants. Another possible limitation of included studies is that none of the studies controlled participants’ dietary intake (e.g., sodium).

Conclusion

Our meta-analysis showed that exercise training led to a reduction in some RAAS parameters (angiotensin-II and aldosterone), SNS activity (norepinephrine) and overall BP. Exercise training may induce a reduction in some aspects of RAAS activity and this might play a vital role in the post-training BP response despite the unobserved change in plasma renin activity. Given the limited study data available for the assessment of changes in the parameters of RAAS, SNS activity and electrolytes, future research is warranted to evaluate the role of RAAS, SNS activity and electrolytes in BP response following exercise training and possible relationship between BP changes.